test44
https://www.cytel.com/blog/statistical-leaders-and-the-future-of-drug-development
September 28, 2022
The landscape of drug development has changed dramatically over the last few decades, and effective statistical leaders..
Read article
test44
https://www.cytel.com/blog/adaptive-trials-at-the-mainstream-of-drug-development
September 23, 2022
Adaptive trial designs – that is, trials that include a prospectively planned modification based on an interim analysis..
Read article
test44
https://www.cytel.com/blog/u.s.-drug-pricing-reform
September 15, 2022
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022, which includes U.S. drug..
Read article
test44
https://www.cytel.com/blog/on-frequentist-and-bayesian-sequential-clinical-trial-designs
September 12, 2022
In clinical trials, patient enrollment is often staggered, with data collected sequentially. When designing a clinical..
Read article
test44
https://www.cytel.com/blog/developing-synthetic-control-arms-using-bayesian-models
September 9, 2022
A new trend has emerged over the last decade that has changed the way many clinical trials are conducted. Unlike..
Read article
test44
https://www.cytel.com/blog/cytel-to-present-at-the-asa-biopharmaceutical-section-regulatory-industry-statistics-workshop
September 8, 2022
The American Statistical Association Biopharmaceutical Section, in cooperation with the FDA Statistical Association,..
Read article
test44
https://www.cytel.com/blog/summer-weekend-read-roundup
September 2, 2022
Last week, we featured our final Summer Weekend Read, the last in a series designed to showcase some of our most recent..
Read article
test44
https://www.cytel.com/blog/discover-the-value-of-an-optimized-clinical-data-strategy
August 26, 2022
To continue our Summer Weekend Reads series, Cytel presents “Discover the Value of an Optimized Clinical Data Strategy”..
Read article
test44
https://www.cytel.com/blog/cytel-presents-at-icpe-2022
August 25, 2022
The International Society for Pharmacoepidemiology is hosting its “ICPE 2022: Advancing Pharmacoepidemiology and..
Read article
